Crescent Capital BDC, Inc. (NASDAQ: CCAP) had its price target raised by analysts at Wells Fargo & Company from $16.50 to $18.00. They now have an "equal weight" rating on the stock.
Crescent Capital BDC, Inc. (NASDAQ: CCAP) had its price target raised by analysts at Raymond James from $18.00 to $19.00. They now have an "outperform" rating on the stock.
Crescent Capital BDC, Inc. (NASDAQ:CCAP) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Crescent Capital BDC (CCAP) Q1 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
Crescent Capital BDC, Inc. Reports First Quarter Net Investment Income Per Share of $0.63 and NAV Per Share of $20.28; Increases Quarterly Dividend [Yahoo! Finance]